Swog Cancer
myeloMATCH to use genomics to enroll patients into target-based leukemia trials
A new initiative to rapidly place individuals with acute myeloid leukemia or myelodysplastic syndrome in clinical trials based on their genomic profiles has opened in the United States and Canada.
Extended lymphadenectomy does not improve bladder cancer outcomes, increases morbidity
Extended lymphadenectomy offered no survival benefit for patients with localized muscle-invasive bladder cancer compared with bilateral standard lymphadenectomy for patients undergoing radical cystectomy, according to study findings.
Expanding clinical trial diversity requires ‘showing up’ in the community to build trust
Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.
Researchers employ cryocompression to prevent chemotherapy-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event associated with taxane-based chemotherapy.
Affordable Care Act increased cancer trial participation among Medicaid-insured patients
Expansion of the Affordable Care Act significantly increased cancer clinical trial participation among patients with Medicaid insurance, according to study results published in JAMA Oncology.
Disparities in cancer clinical trial participation persist, worsened during pandemic
Cancer clinical trial participation appeared lower among Black and Latinx patients compared with white patients with various cancer types, according to study results published in JAMA Network Open.
Phase 3 study of lung cancer regimen designed to be a model for increasing trial diversity
Researchers have begun enrolling patients in Pragmatica-Lung, an NCI-supported phase 3 study designed specifically to eliminate barriers to clinical trial accessibility and participation.
NCI-funded clinical trials add 14.2M life-years for patients with cancer over 4 decades
Clinical trials performed within the NCI’s National Clinical Trials Network during the past 40 years prolonged the lives of patients with cancer by at least 14.2 million life-years, according to a study in Journal of Clinical Oncology.
Medicaid expansion under ACA appears to improve cancer clinical trial access
CHICAGO — The Affordable Care Act’s expansion of Medicaid resulted in a nearly threefold increase in the percentage of patients using Medicaid in cancer trials by early 2020, according to study results presented during ASCO Annual Meeting.
Women at greater risk for more severe adverse events from cancer treatments
Women demonstrated a 34% increased risk for severe adverse events from any cancer treatment compared with men, according to a study published in Journal of Clinical Oncology.